Hims & Hers Health Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Hims & Hers Health Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- HIMS
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001773751
Board of directors
-
Alex Bard · DirectorSince 2023
-
Ambar Bhattacharyya · DirectorSince 2023
-
Andrew Dudum · Director · Chief Executive OfficerSince 2023
-
Anja Manuel · DirectorSince 2024
-
Christiane Pendarvis · DirectorSince 2023
-
Christopher D. Payne · DirectorSince 2024
-
David B. Wells · DirectorSince 2023
-
Deborah M. Autor · Director · Chief Policy OfficerSince 2024
-
Delos M. Cosgrove · DirectorSince 2023
-
Garcia Andrea G. Perez · DirectorSince 2023
-
Jules A. Maltz · DirectorSince 2023
-
Kare Schultz · DirectorSince 2024
-
Kofi Owusu Amoo-Gottfried · DirectorSince 2026
-
Kristen Green · DirectorSince 2023
-
Lynne Chou O'Keefe · DirectorSince 2023
-
Patrick Harrison Carroll · Director · Chief Medical OfficerSince 2023
Chief executives
Andrew Dudum
· Chief Executive Officer
Dates unknown
Board connections
7 of this board's directors also sit on 11 other boards.
- via Delos M. Cosgrove
- via Deborah M. Autor
- via Christopher D. Payne
- via Christopher D. Payne
- via Delos M. Cosgrove
- via Christiane Pendarvis
- via Kofi Owusu Amoo-Gottfried
- via Kristen Green
- via David B. Wells
- via Kofi Owusu Amoo-Gottfried
- via David B. Wells
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,173,216
- 1 purchase by 1 insider
- Sold, last 12 months
- $37,000,748
- 59 sales by 9 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Option exercise | +14,000 | $5.01 | $70,140 |
| Sep 22, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Open-market sale | −29,277 | $29.95 | $876,846 |
| Sep 17, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Open-market sale | −12,313 | $28.82 | $354,861 |
| Sep 16, 2026 | Boughton Soleil Officer (Chief Legal Officer) | Open-market sale | −6,236 | $27.86 | $173,735 |
| Sep 15, 2026 | Chi Michael Officer (Chief Operating Officer) | Open-market sale | −14,027 | $28.39 | $398,227 |
| Sep 15, 2026 | Mohamed Elshenawy Officer (CTO) | Open-market sale | −7,954 | $28.39 | $225,814 |
| Sep 2, 2026 | Boughton Soleil Officer (Chief Legal Officer) | Open-market sale | −3,458 | $28.33 | $97,965 |
| Aug 27, 2026 | Andrew Dudum Director, Officer (Chief Executive Officer), 10% owner | Other | −977,566 | — | — |
| Aug 25, 2026 | Andrew Dudum Director, Officer (Chief Executive Officer), 10% owner | Gift | −463,289 | — | — |
| Aug 19, 2026 | Boughton Soleil Officer (Chief Legal Officer) | Open-market sale | −25,111 | $27.55 | $691,808 |
| Aug 19, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Option exercise | +4,938 | $5.01 | $24,739 |
| Aug 19, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Open-market sale | −4,938 | $29.99 | $148,111 |
| Aug 18, 2026 | Deborah M. Autor Director, Officer (Chief Policy Officer) | Open-market sale | −16,773 | $27.85 | $467,128 |
| Aug 17, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Option exercise | +9,388 | $5.01 | $47,034 |
| Aug 17, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Open-market sale | −9,388 | $27.89 | $261,802 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.